KLF4 and SOX9 transcription factors antagonize β-catenin and inhibit TCF-activity in cancer cells

Hassan Sellak, Songwei Wu, Thomas M. Lincoln

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The transcriptional activator β-catenin is a key mediator of the canonical Wnt signaling pathway. β-catenin itself does not bind DNA but functions via interaction with T-cell factor (TCF)/lymphoid-enhancing factor (LEF) transcription factors. Thus, in the case of active Wnt signaling, β-catenin, in cooperation with TCF/LEF proteins family, activates the expression of a wide variety of genes. To date, the list of established β-catenin interacting targets is far from complete. In this study, we aimed to establish the interaction between β-catenin and transcription factors that might affect TCF activity. We took advantage of EMSA, using TCF as a probe, to screen oligonucleotides known to bind specific transcription factors that might dislodge or antagonize β-catenin/TCF binding. We found that Sox9 and KLF4 antagonize β-catenin/TCF binding in HEK293, A549, SW480, and T47D cells. This inhibition of TCF binding was concentration-dependent and correlated to the in vitro TCF-luciferase functional assays. Overexpression of Sox9 and KLF4 transcription factors in cancer cells shows a concentration-dependent reduction of TCF-luciferase as well as the TCF-binding activities. In addition, we demonstrated that both Sox9 and KLF4 interact with β-catenin in an immunoprecipitation assay and reduce its binding to TCF4. Together, these results demonstrate that Sox9 and KLF4 transcription factors antagonize β-catenin/TCF in cancer cells.

Original languageEnglish (US)
Pages (from-to)1666-1675
Number of pages10
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1823
Issue number10
DOIs
StatePublished - Oct 1 2012

Fingerprint

SOX9 Transcription Factor
TCF Transcription Factors
Catenins
Neoplasms
Transcription Factors
Wnt Signaling Pathway
Luciferases
Immunoprecipitation

Keywords

  • Cancer
  • KLF4
  • Sox9
  • T-cell factor
  • Wnt signaling
  • β-catenin

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

KLF4 and SOX9 transcription factors antagonize β-catenin and inhibit TCF-activity in cancer cells. / Sellak, Hassan; Wu, Songwei; Lincoln, Thomas M.

In: Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1823, No. 10, 01.10.2012, p. 1666-1675.

Research output: Contribution to journalArticle

@article{9edd78c56015403ab2e8815cc8333313,
title = "KLF4 and SOX9 transcription factors antagonize β-catenin and inhibit TCF-activity in cancer cells",
abstract = "The transcriptional activator β-catenin is a key mediator of the canonical Wnt signaling pathway. β-catenin itself does not bind DNA but functions via interaction with T-cell factor (TCF)/lymphoid-enhancing factor (LEF) transcription factors. Thus, in the case of active Wnt signaling, β-catenin, in cooperation with TCF/LEF proteins family, activates the expression of a wide variety of genes. To date, the list of established β-catenin interacting targets is far from complete. In this study, we aimed to establish the interaction between β-catenin and transcription factors that might affect TCF activity. We took advantage of EMSA, using TCF as a probe, to screen oligonucleotides known to bind specific transcription factors that might dislodge or antagonize β-catenin/TCF binding. We found that Sox9 and KLF4 antagonize β-catenin/TCF binding in HEK293, A549, SW480, and T47D cells. This inhibition of TCF binding was concentration-dependent and correlated to the in vitro TCF-luciferase functional assays. Overexpression of Sox9 and KLF4 transcription factors in cancer cells shows a concentration-dependent reduction of TCF-luciferase as well as the TCF-binding activities. In addition, we demonstrated that both Sox9 and KLF4 interact with β-catenin in an immunoprecipitation assay and reduce its binding to TCF4. Together, these results demonstrate that Sox9 and KLF4 transcription factors antagonize β-catenin/TCF in cancer cells.",
keywords = "Cancer, KLF4, Sox9, T-cell factor, Wnt signaling, β-catenin",
author = "Hassan Sellak and Songwei Wu and Lincoln, {Thomas M.}",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.bbamcr.2012.06.027",
language = "English (US)",
volume = "1823",
pages = "1666--1675",
journal = "Biochimica et Biophysica Acta - Molecular Cell Research",
issn = "0167-4889",
publisher = "Elsevier",
number = "10",

}

TY - JOUR

T1 - KLF4 and SOX9 transcription factors antagonize β-catenin and inhibit TCF-activity in cancer cells

AU - Sellak, Hassan

AU - Wu, Songwei

AU - Lincoln, Thomas M.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - The transcriptional activator β-catenin is a key mediator of the canonical Wnt signaling pathway. β-catenin itself does not bind DNA but functions via interaction with T-cell factor (TCF)/lymphoid-enhancing factor (LEF) transcription factors. Thus, in the case of active Wnt signaling, β-catenin, in cooperation with TCF/LEF proteins family, activates the expression of a wide variety of genes. To date, the list of established β-catenin interacting targets is far from complete. In this study, we aimed to establish the interaction between β-catenin and transcription factors that might affect TCF activity. We took advantage of EMSA, using TCF as a probe, to screen oligonucleotides known to bind specific transcription factors that might dislodge or antagonize β-catenin/TCF binding. We found that Sox9 and KLF4 antagonize β-catenin/TCF binding in HEK293, A549, SW480, and T47D cells. This inhibition of TCF binding was concentration-dependent and correlated to the in vitro TCF-luciferase functional assays. Overexpression of Sox9 and KLF4 transcription factors in cancer cells shows a concentration-dependent reduction of TCF-luciferase as well as the TCF-binding activities. In addition, we demonstrated that both Sox9 and KLF4 interact with β-catenin in an immunoprecipitation assay and reduce its binding to TCF4. Together, these results demonstrate that Sox9 and KLF4 transcription factors antagonize β-catenin/TCF in cancer cells.

AB - The transcriptional activator β-catenin is a key mediator of the canonical Wnt signaling pathway. β-catenin itself does not bind DNA but functions via interaction with T-cell factor (TCF)/lymphoid-enhancing factor (LEF) transcription factors. Thus, in the case of active Wnt signaling, β-catenin, in cooperation with TCF/LEF proteins family, activates the expression of a wide variety of genes. To date, the list of established β-catenin interacting targets is far from complete. In this study, we aimed to establish the interaction between β-catenin and transcription factors that might affect TCF activity. We took advantage of EMSA, using TCF as a probe, to screen oligonucleotides known to bind specific transcription factors that might dislodge or antagonize β-catenin/TCF binding. We found that Sox9 and KLF4 antagonize β-catenin/TCF binding in HEK293, A549, SW480, and T47D cells. This inhibition of TCF binding was concentration-dependent and correlated to the in vitro TCF-luciferase functional assays. Overexpression of Sox9 and KLF4 transcription factors in cancer cells shows a concentration-dependent reduction of TCF-luciferase as well as the TCF-binding activities. In addition, we demonstrated that both Sox9 and KLF4 interact with β-catenin in an immunoprecipitation assay and reduce its binding to TCF4. Together, these results demonstrate that Sox9 and KLF4 transcription factors antagonize β-catenin/TCF in cancer cells.

KW - Cancer

KW - KLF4

KW - Sox9

KW - T-cell factor

KW - Wnt signaling

KW - β-catenin

UR - http://www.scopus.com/inward/record.url?scp=84864507806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864507806&partnerID=8YFLogxK

U2 - 10.1016/j.bbamcr.2012.06.027

DO - 10.1016/j.bbamcr.2012.06.027

M3 - Article

C2 - 22766303

AN - SCOPUS:84864507806

VL - 1823

SP - 1666

EP - 1675

JO - Biochimica et Biophysica Acta - Molecular Cell Research

JF - Biochimica et Biophysica Acta - Molecular Cell Research

SN - 0167-4889

IS - 10

ER -